Canary Wharf Group and Kadans Science Partner have formed a joint venture to develop a new 750,000 sq ft GIA life-science focused, wet lab enabled building on the 3.3ha North Quay site.
The 22-storey 750,000sq ft building will be the largest commercial wet lab enabled life science building in Europe.
The building, designed by KPF and built to the highest environmental and technological requirements, will draw on Kadans' experience creating a multi-let lab and office developments with thriving communities. The structure will house SME's, academia, as well as global healthcare and pharmaceutical firms, creating a campus under one roof.
Shobi Khan, CEO Canary Wharf Group, commnted: “Canary Wharf Group has been developing a vision for health and life sciences since 2019 and we are proud to be working with an exceptional partner in Kadans, the European leader in the development and management of life sciences buildings and ecosystems.”
“We are creating a world class building that will provide state of the art laboratory, office and innovation space for some of the most exciting and fast-growing businesses in the health and life sciences sector.”
“Canary Wharf is a true live, work and play destination, with 20 acres of outdoor green space, 5 km of dockside boardwalks, hundreds of shops, restaurants and leisure facilities. We have developed 2,300 apartments on site with another 2,300 homes currently under construction – we have homes for every income level, which will enable researchers and their colleagues to live close by.”
“There could not be a better environment for the U.K.’s most innovative life sciences businesses.”
Michel Leemhuis, CEO of, Kadans Science Partner said: “Kadans aims to contribute to the innovative power of the life sciences sector by developing state-of-the-art lab buildings as well as offering support and an international community.”
“This joint venture with Canary Wharf Group, which is fully supported by our sponsor and partner AXA IM Alts, provides us with a rare opportunity to not only develop a significant and sustainable new life sciences lab building, which will be the largest in Europe, but also for it to be the catalyst for a new world-leading life sciences cluster and ecosystem in the U.K. capital.”
“The Canary Wharf district offers exceptional connectivity, providing access to a huge talent pool and numerous funding partners from its existing tenant base, which will be a highly compelling combination for potential occupiers as well as an exceptional addition to our existing network.”
Cushman & Wakefield advised CWG and JLL advised Kadans.